OKYO Pharma Ownership | Who Owns OKYO Pharma?
OKYO Pharma Ownership Summary
OKYO Pharma is owned by 0.13% institutional investors, and 99.87% retail investors. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.04% of its assets in OKYO Pharma shares.
OKYO Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | OKYO Pharma | 0.13% | - | 99.87% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2023 | 1 | - | 19,807 | 163.29% | - | 5276.35% | 1 | - | - | - |
Dec 31, 2022 | 1 | - | 7,523 | 536.46% | - | 81597.44% | 1 | - | - | -100.00% |
Sep 30, 2022 | 1 | -50.00% | 1,182 | -96.13% | - | 19.09% | - | -100.00% | 1 | - |
Jun 30, 2022 | 2 | - | 30,531 | - | - | - | 2 | - | - | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Nasdaq Composite Index | 12.09K | 0.04% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 15, 2023 | BRANCACCIO JOHN P | - | Buy | $25.00K |
May 19, 2022 | CERRONE GABRIELE M | Executive Chairman | Buy | $440.80K |
May 19, 2022 | JACOB GARY S | Chief Executive Officer | Buy | $50.00K |
May 19, 2022 | CERRONE GABRIELE M | Non-Executive Chairman | Buy | $150.00K |
May 17, 2022 | CERRONE GABRIELE M | Non-Executive Chairman | Buy | $96.75K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2022 Q2 | 5 | - |
OKYO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools